المؤلفون: Michal Stark, Elisa Giovannetti, Gerrit Jansen, Larry H. Matherly, Maria Gemelli, Godefridus J. Peters, Erik Thunnissen, Ittai B. Muller, Zhanjun Hou, P. A. Zucali, E. A. Struys, Niccola Funel, M. Perrino, Yehuda G. Assaraf

المساهمون: Medical oncology laboratory, CCA - Cancer biology and immunology, Pathology, Clinical chemistry, AGEM - Inborn errors of metabolism, AGEM - Endocrinology, metabolism and nutrition, Rheumatology, AGEM - Digestive immunity

المصدر: Annals of Oncology, 28(11), 2725-2732. Oxford University Press
Giovannetti, E, Zucali, P A, Assaraf, Y G, Funel, N, Gemelli, M, Stark, M, Thunnissen, E, Hou, Z, Muller, I B, Struys, E A, Perrino, M, Jansen, G, Matherly, L H & Peters, G J 2017, ' Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma : Clinical evidence and new pharmacological tools ', Annals of Oncology, vol. 28, no. 11, pp. 2725-2732 . https://doi.org/10.1093/annonc/mdx499Test

مصطلحات موضوعية: Male, Mesothelioma, 0301 basic medicine, Oncology, Thymidylate synthase, Immunoenzyme Techniques, Reduced Folate Carrier Protein, chemistry.chemical_compound, 0302 clinical medicine, Tumor Cells, Cultured, Aged, 80 and over, biology, Hematology, Methylation, Middle Aged, Prognosis, Survival Rate, Pemetrexed, 030220 oncology & carcinogenesis, Antifolate, Immunohistochemistry, Female, Proton-Coupled Folate Transporter, medicine.drug, Adult, medicine.medical_specialty, Pleural Neoplasms, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Gene silencing, Survival rate, Aged, Cell Proliferation, business.industry, Original Articles, Thymidylate Synthase, medicine.disease, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, biology.protein, Folic Acid Antagonists, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ccf6187f967e64fb83a9f2dcd466830Test
https://doi.org/10.1093/annonc/mdx499Test

المؤلفون: Carlotta Granchi, Elisa Giovannetti, Amir Avan, Babette Aicher, Daniela Massihnia, Mina Maftouh, Leticia G. Leon, Rajiv S. Raktoe, Anne van Krieken, Niccola Funel, Filippo Minutolo, Antonio Russo, Ugo Boggi, Godefridus J. Peters

المساهمون: Massihnia, D., Avan, A., Funel, N., Maftouh, M., Van Krieken, A., Granchi, C., Raktoe, R., Boggi, U., Aicher, B., Minutolo, F., Russo, A., Leon, L., Peters, G., Giovannetti, E., CCA - Cancer biology and immunology, AGEM - Digestive immunity, Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system

المصدر: Massihnia, D, Avan, A, Funel, N, Maftouh, M, Van Krieken, A, Granchi, C, Raktoe, R, Boggi, U, Aicher, B, Minutolo, F, Russo, A, Leon, L G, Peters, G J & Giovannetti, E 2017, ' Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer ', Journal of Hematology and Oncology, vol. 10, no. 1, 9 . https://doi.org/10.1186/s13045-016-0371-1Test
Journal of Hematology & Oncology
Journal of Hematology and Oncology, 10(1):9. BioMed Central
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-17 (2017)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Biopsy, AKT1, Apoptosis, Akt, Gemcitabine, Pancreatic ductal adenocarcinoma, Synergism, Hematology, Molecular Biology, Deoxycytidine, 0302 clinical medicine, Cell Movement, Tumor Cells, Cultured, Glucose Transporter Type 1, medicine.diagnostic_test, Chemistry, Cell Cycle, Pancreatic Neoplasm, Drug Synergism, lcsh:Diseases of the blood and blood-forming organs, Cell cycle, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Aged, Carcinoma, Pancreatic Ductal, Female, Humans, Pancreatic Neoplasms, Phosphoproteins, Proto-Oncogene Proteins c-akt, RNA, Messenger, Spheroids, Cellular, 030220 oncology & carcinogenesis, Phosphoprotein, medicine.drug, Human, medicine.medical_specialty, Prognosi, lcsh:RC254-282, Flow cytometry, 03 medical and health sciences, Internal medicine, Pancreatic cancer, medicine, Protein kinase B, PI3K/AKT/mTOR pathway, lcsh:RC633-647.5, Research, Apoptosi, medicine.disease, 030104 developmental biology, Cancer cell, Cancer research

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0527d043c396c119ac955e1ab571ea8Test
https://research.vumc.nl/en/publications/e3915272-5f2e-4b5f-a149-4af093da963cTest

المؤلفون: Enrico Vasile, Carmelo Tibaldi, G. Leticia Leon, Elisa Giovannetti, Armida D'Incecco

المساهمون: Medical oncology laboratory, CCA - Innovative therapy

المصدر: Journal of Cancer Research and Clinical Oncology, 141(7), 1189-1194. Springer Verlag
Vasile, E, Tibaldi, C, Leon, G L, D'Incecco, A & Giovannetti, E 2015, ' Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients ', Journal of Cancer Research and Clinical Oncology, vol. 141, no. 7, pp. 1189-1194 . https://doi.org/10.1007/s00432-014-1880-3Test

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, CYP1B1, medicine.medical_treatment, non-small cell lung cancer (NSCLC), Antineoplastic Agents, Single-nucleotide polymorphism, Docetaxel, Polymorphism, Single Nucleotide, Biomarkers, Pharmacological, Polymorphism (computer science), Carcinoma, Non-Small-Cell Lung, Internal medicine, Tumor Cells, Cultured, medicine, Carcinoma, Humans, neoplasms, Genetic Association Studies, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, Hematology, business.industry, General Medicine, Middle Aged, Prognosis, medicine.disease, body regions, Treatment Outcome, Chemotherapy, Adjuvant, Cytochrome P-450 CYP1B1, Female, Taxoids, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5595da0c67b8409b2e8a1b7b1b23d1Test
https://research.vumc.nl/en/publications/96018efa-575a-443a-b58a-d1486c35ebb8Test

المؤلفون: Alfredo Falcone, Ugo Boggi, G.J. Peters, Franco Mosca, Gerrit A. Meijer, Elisa Giovannetti, Niccola Funel, A.G. van der Velde, S. Caponi, Libero Santarpia, Geert Kazemier, Adam E Frampton, Henk M.W. Verheul, Enrico Vasile, Long R. Jiao, N De Lio

المساهمون: Pathology, Surgery, Medical oncology, Medical oncology laboratory, CCA - Disease profiling

المصدر: Annals of Oncology, 24(3), 734-741. Oxford University Press
Caponi, S, Funel, N, Frampton, A E, Mosca, F, Santarpia, L, van der Velde, A G, Jiao, L R, De Lio, N, Falcone, A, Kazemier, G, Meijer, G A, Verheul, H M W, Vasile, E, Peters, G J, Boggi, U & Giovannetti, E 2013, ' The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms ', Annals of Oncology, vol. 24, no. 3, pp. 734-741 . https://doi.org/10.1093/annonc/mds513Test
Università di Pisa-IRIS

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Pathology, Multivariate analysis, Kaplan-Meier Estimate, Gastroenterology, Disease-Free Survival, miR-155, Internal medicine, medicine, Carcinoma, Humans, Neoplasm Invasiveness, Prospective cohort study, Aged, Proportional Hazards Models, Aged, 80 and over, Proportional hazards model, business.industry, Hazard ratio, Hematology, Middle Aged, medicine.disease, Adenocarcinoma, Mucinous, Confidence interval, Pancreatic Neoplasms, Adenocarcinoma, Papillary, MicroRNAs, Oncology, Lymphatic Metastasis, Multivariate Analysis, Adenocarcinoma, Female, business, Carcinoma, Pancreatic Ductal

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bae444b08d57f79eb53f15a00973070Test
https://research.vumc.nl/en/publications/549079eb-2b09-49bf-b086-a35af48aefbfTest

المؤلفون: I. Garassino, Jose A. Rodriguez, Giovanni Luca Ceresoli, Giuseppe Giaccone, Armando Santoro, Paolo Andrea Zucali, Paolo M. Comoglio, Elisa Giovannetti, Massimo Roncalli, Karijn Floor, Annarita Destro, Marielle Gallegos Ruiz, Marileila Varella-Garcia

المساهمون: Medical oncology laboratory, Medical oncology, CCA - Innovative therapy

المصدر: Ann Oncol
Annals of Oncology, 19(9), 1605-1612. Oxford University Press
Zucali, P A, Ruiz, M G, Giovannetti, E, Destro, A, Varella-Garcia, M, Floor, K, Ceresoli, G L, Rodriguez, J A, Garassino, I, Comoglio, P, Roncalli, M, Santoro, A & Giaccone, G 2008, ' Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors ', Annals of Oncology, vol. 19, no. 9, pp. 1605-1612 . https://doi.org/10.1093/annonc/mdn240Test

مصطلحات موضوعية: Male, Lung Neoplasms, Kaplan-Meier Estimate, medicine.disease_cause, Tyrosine-kinase inhibitor, Cohort Studies, chemistry.chemical_compound, Carcinoma, Non-Small-Cell Lung, In Situ Hybridization, Fluorescence, Biopsy, Needle, Gefitinib, Hematology, Middle Aged, Protein-Tyrosine Kinases, Immunohistochemistry, ErbB Receptors, Gene Expression Regulation, Neoplastic, Treatment Outcome, Oncology, Female, KRAS, Growth inhibition, medicine.drug, medicine.drug_class, Blotting, Western, medicine, Humans, Lung cancer, neoplasms, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Probability, Proportional Hazards Models, business.industry, Cancer, medicine.disease, Survival Analysis, respiratory tract diseases, lung cancer, chemistry, Drug Resistance, Neoplasm, Multivariate Analysis, Mutation, Cancer research, Quinazolines, Drug Screening Assays, Antitumor, business, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4970f6bb5f4cef2f3972f8facf3929Test
https://europepmc.org/articles/PMC7360138Test/

المؤلفون: Laura Vroling, Eddy Supriyadi, Godefridus J. Peters, Anjo J.P. Veerman, Antonino Azzarello, Dewa G. Ugrasena, Jacqueline Cloos, Desiree de Lange, Elisa Giovannetti

المساهمون: Medical oncology laboratory, Pediatric surgery, Hematology laboratory, CCA - Innovative therapy

المصدر: Giovannetti, E, Ugrasena, D G, Supriyadi, E, Vroling, L, Azzarello, A, de Lange, D, Peters, G J, Veerman, A J P & Cloos, J 2008, ' Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia ', Leukemia Research, vol. 32, no. 1, pp. 19-24 . https://doi.org/10.1016/j.leukres.2007.02.011Test
Leukemia Research, 32(1), 19-24. Elsevier Limited

مصطلحات موضوعية: Adult, Male, Cancer Research, 5,10-Methylenetetrahydrofolate, Thymidylate synthase, chemistry.chemical_compound, Polymorphism (computer science), Ethnicity, Humans, Genetic Predisposition to Disease, Methionine synthase, Child, Promoter Regions, Genetic, Methylenetetrahydrofolate Reductase (NADPH2), Netherlands, Genetics, Polymorphism, Genetic, biology, Deoxyuridine monophosphate, Hematology, (Methionine synthase) reductase, Thymidylate Synthase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, MTRR, Methotrexate, Oncology, chemistry, Drug Resistance, Neoplasm, Indonesia, Tandem Repeat Sequences, Methylenetetrahydrofolate reductase, Child, Preschool, biology.protein, Cancer research, Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a5bdc23deefd4c750ca899f4007724Test
https://research.vumc.nl/en/publications/8151634c-470c-43c4-8df9-4e7854b4ab93Test